+
Connext Tour

Webinar 2022: Management of aortic and mitral valve disease

Torsten Doenst et al. Focus on the management of aortic and mitral valve disease with future treatment in mind. Including quality of life, preserving the long-treatment path, and the role of porcine tissue valves during a recorded webinar.

Related Videos

Now you've got Navitor

AV VALVES 2023: HoloLens Technology

Review the Trends | Mitral focus

AV VALVES 2023:HF and VHD – Patient Management

TAVI Summit 2023: Streamline implantation

M-TEER: primary and secondary Mitral Regurgitation - cases, tips and tricks

Navitor™: Voice of the Experts Mohammed Saad

AV Valves Summit 2024 | Opening of Day 2

TRENDING TOPICS

TAVI Webinar 1- Key learnings for advanced TAVI

TAVI Webinar 1- when the present unlocks the future:key learnings for advances TAVI

Treating Large annuli with 35mm Navitor Vision

Achieving optimal outcomes for treatment of large annuli with 35 mm Navitor Vision Valve

PCR Webinar on secondary mitral regurgitation

New evidence reshaping the management of secondary mitral regurgitation

CONNEXT


HUB
RELATED RESOURCES

PCR LV 2021: Navitor™ 30-day outcomes

PCR LV 2021: Navitor™ Live-in-a-box

ACC 2023: COAPT™ trial

Epic Mitral – 10-Year Clinical Outcomes

CONNEXT


LIVE
RELATED EVENTS

Navigating the Anatomy | Tricuspid focus

Now you've got Navitor.
Stable delivery.

AV VALVES 2023: MR – Acute Rupture

Now you've got Navitor.
Future ready.

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline